Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

203 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Home telemonitoring versus hospital care in complicated pregnancies in the Netherlands: a randomised, controlled non-inferiority trial (HoTeL).
Bekker MN, Koster MPH, Keusters WR, Ganzevoort W, de Haan-Jebbink JM, Deurloo KL, Seeber L, van der Ham DP, Zuithoff NPA, Frederix GWJ, van den Heuvel JFM, Franx A. Bekker MN, et al. Among authors: ganzevoort w. Lancet Digit Health. 2023 Mar;5(3):e116-e124. doi: 10.1016/S2589-7500(22)00231-X. Lancet Digit Health. 2023. PMID: 36828605 Free article. Clinical Trial.
Immediate delivery versus expectant monitoring for hypertensive disorders of pregnancy between 34 and 37 weeks of gestation (HYPITAT-II): an open-label, randomised controlled trial.
Broekhuijsen K, van Baaren GJ, van Pampus MG, Ganzevoort W, Sikkema JM, Woiski MD, Oudijk MA, Bloemenkamp KW, Scheepers HC, Bremer HA, Rijnders RJ, van Loon AJ, Perquin DA, Sporken JM, Papatsonis DN, van Huizen ME, Vredevoogd CB, Brons JT, Kaplan M, van Kaam AH, Groen H, Porath MM, van den Berg PP, Mol BW, Franssen MT, Langenveld J; HYPITAT-II study group. Broekhuijsen K, et al. Among authors: ganzevoort w. Lancet. 2015 Jun 20;385(9986):2492-501. doi: 10.1016/S0140-6736(14)61998-X. Epub 2015 Mar 25. Lancet. 2015. PMID: 25817374 Clinical Trial.
Temporizing management vs immediate delivery in early-onset severe preeclampsia between 28 and 34 weeks of gestation (TOTEM study): An open-label randomized controlled trial.
Duvekot JJ, Duijnhoven RG, van Horen E, Bax CJ, Bloemenkamp KW, Brussé IA, Dijk PH, Franssen MT, Franx A, Oudijk MA, Porath MM, Scheepers HC, van Wassenaer-Leemhuis AG, van Drongelen J, Mol BW, Ganzevoort W; TOTEM study collaboration group. Duvekot JJ, et al. Among authors: ganzevoort w. Acta Obstet Gynecol Scand. 2021 Jan;100(1):109-118. doi: 10.1111/aogs.13976. Epub 2020 Aug 28. Acta Obstet Gynecol Scand. 2021. PMID: 33319930 Free PMC article. Clinical Trial.
Associations of severe adverse perinatal outcomes among continuous birth weight percentiles on different birth weight charts: a secondary analysis of a cluster randomized trial.
Kamphof HD, Gordijn SJ, Ganzevoort W, Verfaille V, Offerhaus PM, Franx A, Pajkrt E, de Jonge A, Henrichs J. Kamphof HD, et al. Among authors: ganzevoort w. BMC Pregnancy Childbirth. 2022 Apr 30;22(1):375. doi: 10.1186/s12884-022-04680-5. BMC Pregnancy Childbirth. 2022. PMID: 35490210 Free PMC article. Clinical Trial.
Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an open-label, multicentre, randomised, controlled trial.
Bistervels IM, Buchmüller A, Wiegers HMG, Ní Áinle F, Tardy B, Donnelly J, Verhamme P, Jacobsen AF, Hansen AT, Rodger MA, DeSancho MT, Shmakov RG, van Es N, Prins MH, Chauleur C, Middeldorp S; Highlow Block writing committee; Highlow Investigators. Bistervels IM, et al. Lancet. 2022 Nov 19;400(10365):1777-1787. doi: 10.1016/S0140-6736(22)02128-6. Epub 2022 Oct 28. Lancet. 2022. PMID: 36354038 Clinical Trial.
OPtimal TIming of antenatal COrticosteroid administration in pregnancies complicated by early-onset fetal growth REstriction (OPTICORE): study protocol of a multicentre, retrospective cohort study.
van de Meent M, Kleuskens DG, Ganzevoort W, Gordijn SJ, Kooi EMW, Onland W, van Rijn BB, Duvekot JJ, Kornelisse RF, Al-Nasiry S, Jellema RK, Knol HM, Manten GTR, Mulder-de Tollenaer SM, Derks JB, Groenendaal F, Bekker MN, Schuit E, Lely AT, Kooiman J. van de Meent M, et al. Among authors: ganzevoort w. BMJ Open. 2023 Mar 17;13(3):e070729. doi: 10.1136/bmjopen-2022-070729. BMJ Open. 2023. PMID: 36931680 Free PMC article.
Predictive value of fetal growth trajectory from 20 weeks of gestation onwards for severe adverse perinatal outcome in low-risk population: secondary analysis of IRIS study.
Kamphof HD, van Roekel M, Henrichs J, de Vreede H, Verhoeven CJ, Franx A, de Jonge A, Ganzevoort W, Gordijn SJ. Kamphof HD, et al. Among authors: ganzevoort w. Ultrasound Obstet Gynecol. 2023 Dec;62(6):796-804. doi: 10.1002/uog.26250. Ultrasound Obstet Gynecol. 2023. PMID: 37204332 Free article.
Doppler ultrasound of umbilical and middle cerebral artery in third trimester small-for-gestational age fetuses to decide on timing of delivery for suspected fetal growth restriction: A cohort with nested RCT (DRIGITAT).
Marijnen MC, Kamphof HD, Damhuis SE, Smies M, Leemhuis AG, Wolf H, Gordijn SJ, Ganzevoort W; DRIGITAT Trial Group. Marijnen MC, et al. Among authors: ganzevoort w. BJOG. 2024 Jul;131(8):1042-1053. doi: 10.1111/1471-0528.17770. Epub 2024 Feb 5. BJOG. 2024. PMID: 38498267 Clinical Trial.
203 results